MORINO Fumitoshi | Digestive Disease and Hepatology Center, Tokai University Tokyo Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon α-2a in the treatment of chronic hepatitis C
Increases Over the Past 10 Years in Fatty Liver, Non-alcoholic Fatty Liver and Suspicious Non-alcoholic Steatohepatitis as Seen in Ultrasound Examinations Attending General Health Check-ups

スポンサーリンク